Cite
HARVARD Citation
Neukirchen, J. et al. (n.d.). 231 UPDATE OF RESPONSE TO TREATMENT WITH AZACITIDINE AND DECITABINE IN HIGH-RISK MDS PATIENTS FROM THE DUESSELDORF MDS REGISTRY – 10 YEARS EXPERIENCE WITH HYPOMETHYLATING TREATMENT. Leukemia research. 39 (1), pp. S115-S116. [Online].